Literature DB >> 32650464

Motor and Cognitive Performance in Patients with Liver Cirrhosis with Minimal Hepatic Encephalopathy.

Constanza San Martín-Valenzuela1,2,3, Aroa Borras-Barrachina1, Juan-José Gallego4, Amparo Urios4, Víctor Mestre-Salvador1, Patricia Correa-Ghisays3,5, María-Pilar Ballester4,6, Desamparados Escudero-García6,7, Joan Tosca6, Cristina Montón6, María-Pilar Ríos8, Elena Kosenko9, Vicente Felipo10, Rafael Tabares-Seisdedos1,3,7, Gabriel Selva-Vera1,3,11, Carmina Montoliu4,12.   

Abstract

Minimal hepatic encephalopathy (MHE) is associated with mild cognitive impairment and frailty. This study aims to identify cognitive and motor differences in cirrhotic patients with and without MHE, and the correlations between motor signs and cognitive performance. Gait, balance, hand strength and motor speed performance were evaluated in 66 cirrhotic patients (38 without and 28 with MHE, according to the Psychometric Hepatic Encephalopathy Score (PHES). Cognitive performance was measured with the Mini-Mental State Examination, Verbal Fluency Test, Aprendizaje Verbal España-Complutense Test (TAVEC), Wechsler Adult Intelligence Scale III, Hamilton Depression and Anxiety Rating Scale and Functioning Assessment Short Test (FAST). MHE patients performed worse than patients without MHE in cognitive and autonomous functioning, learning and long-term memory, and verbal fluency. The same pattern was found in gait, center of pressure movement, variability of hand strength performance and hand motor speed. In MHE patients, high correlations were found between balance and FAST test, gait velocity and verbal skills, hand strength variability and anxiety and depression, and motor speed and FAST and TAVEC. MHE patients showed worse motor and cognitive performance than patients without MHE. MHE patients could have impaired movement control expressed as bradykinesia, and this reduced motor performance could correlate with cognitive performance.

Entities:  

Keywords:  biomechanics measurements; cognitive assessment; minimal hepatic encephalopathy

Year:  2020        PMID: 32650464     DOI: 10.3390/jcm9072154

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  1 in total

1.  Immune-Inflammatory Biomarkers Predict Cognition and Social Functioning in Patients With Type 2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: A 1-Year Follow-Up Study.

Authors:  Marta Garés-Caballer; Joan Vicent Sánchez-Ortí; Patricia Correa-Ghisays; Vicent Balanzá-Martínez; Gabriel Selva-Vera; Joan Vila-Francés; Rafael Magdalena-Benedito; Constanza San-Martin; Victor M Victor; Irene Escribano-Lopez; Antonio Hernandez-Mijares; Juliana Vivas-Lalinde; Eduard Vieta; Juan C Leza; Rafael Tabarés-Seisdedos
Journal:  Front Neurol       Date:  2022-06-02       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.